Effects of 17β-estradiol on the Expression Caveolin-1 and Type Ⅲ Collagen in the Mouse Lung FibroblastStimulated by SiO 2
Abstract
To observe the effects of different concentration of 17β-estradiol (17β-E2) on the expression of Caveolin-1 and type Ⅲ collagen in the mouse lung fibroblast stimulated by SiO2. Methods Fibroblast cells were devided into five groups: blank control group, SiO2 (100 mg/L) group and SiO2 (100 mg/L)+ different concentration of 17β-E2 (10-8,10-7,10-6 mol/L) groups. After treated with different concentration of 17β-E2, for 48 h, the cells were collected, then the expression of Caveolin-1 and of type Ⅲ collagen were examined with immunohistochemistry method. Results Compared with the blank control group, the expression of Caveolin-1 in mouse lung fibroblasts treated by SiO2 significantly decreased (P <0.05), While which in the SiO2+17β-E2 group significantly increased as 17β -E2 dose increased (P < 0.05); There were significantly different in the expression of type Ⅲ collagen among different groups (P <0.05), which in SiO2 group were evidently higher than that in the blank control group, while which in 17β-E2 groups decreased significantly, when compared with SiO2 group (P <0.05); 17β-E2 increased the expression of Caveolin-1 and decreased the expression of type Ⅲ collagen in the dose dependent manner. Correlation analysis showed that 17β-E2 was positive correlated with the expression of Caveolin-1 (r=0.926, P <0.05), and negative correlated with the express of type Ⅲ collagen (r=-0.914, P <0.05), and the expression of Caveolin-1 and the expression of type Ⅲ collagen was negatively correlation (r=-0.887, P <0.05). Conclusion 17β-E2 may inhibit the expression of type Ⅲ collagen by up-regulating the expression of Caveolin-1 in mouse lung fibroblast cell to play a role in the resistance of the lung fibrosis.
Keywords: 17β-estradiol, Lung fibroblast, Caveolin-1, Type Ⅲ collagen
Full Text:
PDFReferences
Liu HM. Zhao XF. Guo LN, et al. Effects of caveolin-1 on the 17beta-estradiol-mediated inhibition of VSMC proliferation induced by vascular injury. Life Sci.2007;80(8) ;800-812.
Gvaramia D. Blaauboer ME. Hanemaaijer R. et al. Role of caveolin-1 in fibrotic diseases. Matrix Bio. 2013; 32 (6);307- 315.
Wang XM. Zhang Y, Kim HP, et al. Caveolin-1; a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med.2006;203(13);2895-2906.
Barth К. Blasche R. Kasper М. Lack of evidence for caveolin- land CD147 interaction before and after bleomycin-induced lung injury. Histochem Cell Biol.2006; 126(5) :563-573.
Zuluaga S. Alvarez-Barrientos A. Gutierrez-Uzquiza A,et al. Negative regulation of Akt activity by p38alpha MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. Cell Signal, 2007; 19 ( 1 ): 62-74.
Tourkina E, Hoffman S. Caveolin-1 signaling in lung fibrosis. Open Rheumatol J, 2012; 6: 116-122. doi: 10. 2174/1874312901206010116. Epub 2012 Jun 15.
Refbacks
- There are currently no refbacks.



